# Ascend Medical reviews (2026): GLP-1 telehealth sellers | This GLP Two package prices are published and neither states what period they cover. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/reviews/ascend-medical Updated: 2026-10-28 By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 A price with no period # Ascend Medical review Two package prices are published and neither states what period they cover. ## The verdict Ascend Medical publishes a Starting Package at $225 for semaglutide and $240 for tirzepatide. Neither states a period. Not per month, not per supply. Neither figure is ranked here. **Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures). Category GLP-1 telehealth Molecule Semaglutide · Tirzepatide Form Injection States 2 Prescription Required Compounded Yes — not FDA-approved Ascend Medical sells both molecules by injection. Two packages carry a figure. Coverage is recorded in two states. 1. ## Who writes the prescription, and what do they see? A prescription precedes dispensing. The pages name packages rather than clinicians. The intake is not documented. Nor is the duration of what is being sold. A package price without a period is not comparable to anything. Two sellers quoting $225 are quoting different products if one covers four weeks and the other twelve. Ascend does not say which it is. 2. ## What happens when the dose goes up? Nothing is published about dose. That question sits underneath the first one. Neither the duration nor the dose is stated. A package like that cannot be priced per milligram or per month. 3. ## What the price includes No figure here can be turned into a monthly cost. $225 might be a month, a supply, or a starting block. The pages do not say. Ask before ordering, and get the answer in writing. Until then, treat both numbers as quotes rather than prices. 4. ## What it claims, and what it cites Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named. ## Where it holds up, and where it does not - Strength: Two packages carry a published figure - Strength: Both molecules are offered - Strength: The word Starting is at least stated - Limitation: No billing period appears anywhere - Limitation: Neither figure can be compared - Limitation: Coverage is recorded in two states - Limitation: No dose information is published ## What the evidence says about this kind of treatment The assessment above is about Ascend Medical. These are about the drugs it sells, and they are traced to the primary literature. - [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1) - [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1) - [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain) Right for A reader prepared to ask what period the package covers before ordering. Wrong for A reader who needs a monthly figure to compare against another seller. ## The evidence behind what Ascend Medical prescribes These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation. - [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review) A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower. - [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points. ## How Ascend Medical compares | Seller | Who it suits | Go | | --- | --- | --- | | Balanced Hormone Health | Readers who would rather see a dose increase priced than hidden in a monthly figure | | | CeliaRx | Readers who prefer a one-time purchase to a subscription and can fund it at once | | | Blue Sky MD | Patients near the practice who will ask what enrollment costs before joining | | [Compare all providers side by side →](https://thisglp.com/best) More GLP-1 telehealth sellers reviews: [Good Girl Rx](https://thisglp.com/reviews/good-girl-rx) [Good Life Meds](https://thisglp.com/reviews/good-life-meds) [GoodRx](https://thisglp.com/reviews/goodrx) [Green Cap Health](https://thisglp.com/reviews/green-cap-health) [Harbor](https://thisglp.com/reviews/harbor) [Harmony Wellness Clinic](https://thisglp.com/reviews/harmony-wellness-clinic) Sponsored alternative SkinnyRx Readers choosing tirzepatide, the one line with a published standing rate ## Frequently asked Is $225 a monthly price? Unknown. Ascend states no period beside either figure — not per month, not per supply. Why is nothing ranked here? A price with no period cannot be compared. Ranking it would put a number on a board that means something different from every other number on it. Where does Ascend operate? Coverage is recorded in two states. Or [compare every seller we cover](https://thisglp.com/best). **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).